Wen-Xian Liu
Overview
Explore the profile of Wen-Xian Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
109
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kang Y, Chen L, Zhu J, Liu W, Ma C
World J Clin Cases
. 2022 Jan;
9(36):11208-11219.
PMID: 35071551
Background: Frailty is prevalent in elderly patients with cardiovascular diseases. However, the association between frailty and in-hospital outcomes for elderly patients with heart failure and reduced ejection (HFrEF) remains unknown....
2.
Yu Q, Zhu J, Liu W
BMC Cardiovasc Disord
. 2020 Apr;
20(1):187.
PMID: 32316910
Background: Diabetes patients presenting with ST-segment elevation myocardial infarction (STEMI) scheduled for primary percutaneous coronary intervention (PCI) have an increased risk of contrast induced-acute kidney injury (CI-AKI). The effects of...
3.
Kang T, Ren Y, Zhao H, Ning S, Liu W
World J Clin Cases
. 2020 Feb;
8(2):255-263.
PMID: 32047773
Background: Fulminant myocarditis is the critical form of myocarditis that is often associated with heart failure, malignant arrhythmia, and circulatory failure. Patients with fulminant myocarditis who end up with severe...
4.
Zhang J, Liu W, Lyu S
Cardiovasc Ther
. 2020 Jan;
2020:4532596.
PMID: 31969933
Objective: This prospective study aimed to evaluate the value of the cardiac cycle time-corrected electromechanical activation time (EMATc) measured at admission for predicting major cardiac adverse events (MACEs) in hospitalized...
5.
Kang Y, Chen L, Kang T, Liu W
Arq Bras Cardiol
. 2019 Sep;
113(3):367-372.
PMID: 31482945
Background: In clinical observation, patients with acute coronary syndrome complicated with peripheral artery disease have poor prognosis, so the relationship between the diseases and clinical characteristics need to be further...
6.
Li S, Sheng J, Zhou Q, Xing W, Liu H, Liu W
Chin J Integr Med
. 2018 Apr;
25(5):366-369.
PMID: 29651673
No abstract available.
7.
Jiao M, You H, Yang X, Yuan H, Li Y, Liu W, et al.
Sci Rep
. 2018 Jan;
8(1):724.
PMID: 29335596
Circulating miRNAs are proposed as a biomarker of heart disease. This study evaluated whether circulating miRNAs could be used as a biomarker for childhood dilated cardiomyopathy (CDCM). A total of...
8.
Pan Q, Ren Y, Liu W, Hu Y, Zheng J, Xu Y, et al.
Nutr Res
. 2015 Jun;
35(7):576-84.
PMID: 26055348
Previous research demonstrated that resveratrol possesses promising properties for preventing obesity. Endoplasmic reticulum (ER) stress was proposed to be involved in the pathophysiology of both obesity and hepatic steatosis. In...
9.
Peierdun M, Liu W, Renaguli A, Nurmuhammat A, Li X, Gulibaier K, et al.
Chin J Integr Med
. 2015 Mar;
21(12):895-901.
PMID: 25749903
Objective: To investigate the distribution of abnormal hilit syndromes in traditional Uighur medicine (TUM) among human immunodeficiency virus infection and acquired immune deficiency syndrome (HIV/AIDS) patients, and to find out...
10.
Pan Q, Ren Y, Zhu J, Hu Y, Zheng J, Fan H, et al.
Nutrients
. 2014 Jul;
6(7):2619-31.
PMID: 25025298
Resveratrol is well known for its anti-inflammation and anti-oxidant properties, and has been shown to be effective in alleviating the development of obesity. The purpose of this investigation was to...